You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 28 No. 2, February 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

David S. Janowsky, MD; M. Khaled El-Yousef, MD; John M. Davis, MD; H. Joseph Sekerke, PhD

Arch Gen Psychiatry. 1973;28(2):185-191.


Abstract

Methylphenidate (Ritalin) hydrochloride was administered intravenously to schizophrenic, manic, and depressed patients during the active phase of their illness and upon recovery and to normal. Methylphenidate was found to activate psychotic symptoms in schizophrenics during the active phase of their illness. It failed to produce this effect in the same patients after remission had occurred. It failed to produce a psychotic reaction in most patients with mania and all normal or depressed patients.



Author Affiliations

Nashville, Tenn

From the departments of psychiatry and pharmacology, Vanderbilt University School of Medicine and the Tennessee Neuropsychiatric Institute, Nashville, Tenn.


Footnotes

Accepted for publication Oct 11, 1972.

Reprint requests to Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, Tenn 37203 (Dr. Janowsky).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Outcomes of public concern in schizophrenia
Kooyman et al.
Br. J. Psychiatry 2007;191:s29-s36.
ABSTRACT | FULL TEXT  

Neural Cell Adhesion Molecule-Secreting Transgenic Mice Display Abnormalities in GABAergic Interneurons and Alterations in Behavior
Pillai-Nair et al.
J. Neurosci. 2005;25:4659-4671.
ABSTRACT | FULL TEXT  

Stimulant psychosis: systematic review
Curran et al.
Br. J. Psychiatry 2004;185:196-204.
ABSTRACT | FULL TEXT  

Substance misuse, psychiatric disorder and violent and disturbed behaviour
SOYKA
Br. J. Psychiatry 2000;176:345-350.
ABSTRACT | FULL TEXT  

Sources of Diagnostic Uncertainty for Chronically Psychotic Cocaine Abusers
Shaner et al.
Psychiatr. Serv. 1998;49:684-690.
ABSTRACT | FULL TEXT  

Autonomic Abnormalities in Schizophrenia: State or Trait Indicators?
Dawson et al.
Arch Gen Psychiatry 1994;51:813-824.
ABSTRACT  

Double-blind Comparison of Alprazolam, Diazepam, and Placebo for the Treatment of Negative Schizophrenic Symptoms
Csernansky et al.
Arch Gen Psychiatry 1988;45:655-659.
ABSTRACT  

The Use of Psychostimulants in General Psychiatry: A Reconsideration
Chiarello and Cole
Arch Gen Psychiatry 1987;44:286-295.
ABSTRACT  

Psychotic Reactions Following the Naive Ingestion of an Anorectic, Phenylpropanolamine, in Psychiatric Patients
Scavullo and Dementi
International Journal of Toxicology 1986;5:577-581.
ABSTRACT  

Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients
Pickar et al.
Science 1984;225:954-957.
ABSTRACT  

Schizophrenia: dopamine beta-hydroxylase activity and treatment response
Sternberg et al.
Science 1982;216:1423-1425.
ABSTRACT  

Long-term Pimozide Pretreatment Differentially Affects Behavioral Responses to Dextroamphetamine in Schizophrenia: Further Exploration of the Dopamine Hypothesis of Schizophrenia
van Kammen et al.
Arch Gen Psychiatry 1982;39:275-281.
ABSTRACT  

The Effect of Methylphenidate on Serum Growth Hormone: Influence of Antipsychotic Drugs and Diagnosis
Janowsky et al.
Arch Gen Psychiatry 1978;35:1384-1389.
ABSTRACT  

Inhibition of Dopamine Synthesis in Chronic Schizophrenia: Clinical Ineffectiveness of Metyrosine
Nasrallah et al.
Arch Gen Psychiatry 1977;34:649-655.
ABSTRACT  

Methylphenidate Hydrochloride Effects on Psychological Tests in Acute Schizophrenic and Nonpsychotic Patients
Janowsky et al.
Arch Gen Psychiatry 1977;34:189-194.
ABSTRACT  

Hyporesponsivity of Chronic Schizophrenic Patients to Dextroamphetamine
Kornetsky
Arch Gen Psychiatry 1976;33:1425-1428.
ABSTRACT  

Methylphenidate, Dextroamphetamine, and Levamfetamine: Effects on Schizophrenic Symptoms
Janowsky and Davis
Arch Gen Psychiatry 1976;33:304-308.
ABSTRACT  

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia
Post et al.
Arch Gen Psychiatry 1975;32:1063-1069.
ABSTRACT  

Amphetamine-Induced Dopaminergic Hypersensitivity in Guinea Pigs: Implications in Psychosis and Human Movement Disorders
Klawans and Margolin
Arch Gen Psychiatry 1975;32:725-732.
ABSTRACT  

Central Dopamine Turnover in Schizophrenic Syndromes
Bowers
Arch Gen Psychiatry 1974;31:50-54.
ABSTRACT  

Drugs, Neurotransmitters, and Schizophrenia
Snyder et al.
Science 1974;184:1243-1253.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.